FY'24 Medium-Term Aspirations

$ in millions $ in millions Investing For Organic Growth Non-GAAP R&D (1,2) - Investing in Innovation $450 $400 12.2% 12.2% $350 11.7% $300 11.3% 11.0% $250 12.0% $200 $412 $426 $365 $150 $100 $317 $317 $274 $50 $- FY'17 FY'18 FY'19 FY'20 FY'21 TTM Q3 FY'22 FY'22 Model: 12%-14% Research & Development ($ and in % of Total Revenues) (1),(2) R&D % of Total Revenues R&D US$ 12-14% 12.2% Future -80% of our investments will be in cloud technologies Non-GAAP Sales & Marketing (1,2) - Investing in Sales Coverage $700 10.5% ᏗᎨ FY'22 Model: 18% - 20% $600 18.8% $194 M $426 M 17.8% 18.5% $500 18.5% 17.8% FY'15 TTM Q3 FY'22 FY'22 $400 19.0% $654 $300 $576 $604 $520 $510 $200 $435 Anticipated $2.2B+ investment in R&D over the next 5 years $100 $- FY'17 FY'18 FY'19 FY'20 FY'21 TTM Q3 FY'22 opentext™ 1. Please refer to "Use of Non-GAAP Financial Measures" at the end of this presentation and "Reconciliation of selected GAAP-based measures to Non-GAAP-based measures" included within our current and historical filings on Forms 10-Q, 10-K and 8-K. 2. Represents % of Total Revenues. OpenText ©2022 All rights reserved 21

View entire presentation